Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRX NASDAQ:DRIO NYSE:ELMD NYSE:INFU On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$7.50-3.8%$8.05$4.30▼$11.30$206.03M0.9283,383 shs160,488 shsDRIODarioHealth$7.99+7.2%$8.46$5.93▼$17.74$54.39M1.0915,860 shs5,537 shsELMDElectromed$25.81+1.0%$24.43$17.73▼$30.73$213.58M0.3957,121 shs34,648 shsINFUInfuSystem$10.62+2.2%$9.63$4.67▼$11.04$214.46M1.49123,084 shs84,913 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%+4.18%-11.54%+14.51%+0.25%DRIODarioHealth0.00%-2.05%-13.48%-33.93%-51.55%ELMDElectromed0.00%-1.54%+9.92%-15.01%+10.25%INFUInfuSystem0.00%-2.72%+11.63%+25.09%+113.81%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$7.50-3.8%$8.05$4.30▼$11.30$206.03M0.9283,383 shs160,488 shsDRIODarioHealth$7.99+7.2%$8.46$5.93▼$17.74$54.39M1.0915,860 shs5,537 shsELMDElectromed$25.81+1.0%$24.43$17.73▼$30.73$213.58M0.3957,121 shs34,648 shsINFUInfuSystem$10.62+2.2%$9.63$4.67▼$11.04$214.46M1.49123,084 shs84,913 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%+4.18%-11.54%+14.51%+0.25%DRIODarioHealth0.00%-2.05%-13.48%-33.93%-51.55%ELMDElectromed0.00%-1.54%+9.92%-15.01%+10.25%INFUInfuSystem0.00%-2.72%+11.63%+25.09%+113.81%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 2.67Moderate Buy$10.5040.00% UpsideDRIODarioHealth 2.25Hold$35.00338.05% UpsideELMDElectromed 3.00Buy$36.6742.06% UpsideINFUInfuSystem 3.00Buy$15.0041.24% UpsideCurrent Analyst Ratings BreakdownLatest DRIO, ELMD, INFU, and CVRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2026CVRXCVRx Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.003/20/2026DRIODarioHealth Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$16.00 ➝ $10.002/24/2026INFUInfuSystem Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$14.00 ➝ $15.002/17/2026CVRXCVRx Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy2/13/2026CVRXCVRx Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$11.00 ➝ $10.002/11/2026ELMDElectromed Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$38.00(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$56.65M3.50N/AN/A$1.50 per share5.00DRIODarioHealth$22.36M2.61N/AN/A$10.05 per share0.80ELMDElectromed$68.86M3.10$0.62 per share41.36$5.10 per share5.06INFUInfuSystem$143.44M1.50$0.83 per share12.79$2.47 per share4.30Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$53.31M-$2.05N/AN/AN/A-94.10%-99.32%-45.83%5/11/2026 (Estimated)DRIODarioHealth-$41.71M-$10.43N/AN/AN/A-186.57%-59.48%-36.94%5/13/2026 (Estimated)ELMDElectromed$5.15M$1.0334.41N/AN/A11.34%15.71%13.37%N/AINFUInfuSystem$870K$0.32177.0334.26N/A1.12%2.78%1.41%N/ALatest DRIO, ELMD, INFU, and CVRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026DRIODarioHealth-$1.48N/AN/AN/A$5.46 millionN/A5/11/2026Q1 2026CVRXCVRx-$0.5043N/AN/AN/A$14.49 millionN/A2/12/2026Q4 2025CVRXCVRx-$0.42-$0.46-$0.04-$0.46$15.75 million$16.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/ADRIODarioHealthN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx1.267.636.72DRIODarioHealth0.453.763.30ELMDElectromedN/A5.104.74INFUInfuSystem0.501.981.59Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%DRIODarioHealth33.39%ELMDElectromed40.82%INFUInfuSystem71.13%Insider OwnershipCompanyInsider OwnershipCVRXCVRx18.90%DRIODarioHealth3.50%ELMDElectromed10.50%INFUInfuSystem10.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.43 million21.44 millionOptionableDRIODarioHealth2007.30 million7.05 millionNo DataELMDElectromed1608.28 million7.36 millionOptionableINFUInfuSystem41020.19 million19.10 millionOptionableDRIO, ELMD, INFU, and CVRX HeadlinesRecent News About These CompaniesInfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026April 30, 2026 | businesswire.comInfuSystem (NYSE:INFU) Shares Down 1.3% - Here's WhyApril 24, 2026 | americanbankingnews.comInfuSystem (NYSE:INFU) Stock Price Down 1.3% - Time to Sell?April 24, 2026 | marketbeat.comInfuSystem: Expecting Strong Stock Gains In 2026April 11, 2026 | seekingalpha.comInfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026March 16, 2026 | finance.yahoo.comInfuSystem stock gains after CFO buys sharesMarch 3, 2026 | in.investing.comInsider Buying: InfuSystem (NYSE:INFU) CFO Buys 2,064 Shares of StockMarch 3, 2026 | insidertrades.comInfuSystem Holdings, Inc. (AMEX:INFU) Q4 2025 Earnings Call TranscriptFebruary 25, 2026 | insidermonkey.comInfuSystem Holdings, Inc. Q4 2025 Earnings Call SummaryFebruary 24, 2026 | finance.yahoo.comInfuSystem ‘makes advances,’ building on tech investmentsFebruary 24, 2026 | hmenews.comHWhy InfuSystem Holdings, Inc.’s (INFU) Stock Is Up 10.29%February 24, 2026 | aaii.comAInfuSystem outlines 6% to 8% revenue growth for 2026 following contract restructuringFebruary 24, 2026 | msn.comInfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call TranscriptFebruary 24, 2026 | seekingalpha.comInfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat EstimatesFebruary 24, 2026 | zacks.comInfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025February 24, 2026 | businesswire.comInfuSystem Sets Date to Report 2025 Financial ResultsFebruary 17, 2026 | tipranks.comInfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026February 17, 2026 | businesswire.comInfuSystem: Regulatory Backed Market CatalystJanuary 30, 2026 | seekingalpha.comCMS to reimburse non-opioid pain pumps in ASCs in 2026December 11, 2025 | beckersasc.comBTwo InfuSystem infusion pumps added by CMS to NOPAIN Act payment listDecember 11, 2025 | msn.comInfuSystem stock rises after pumps added to CMS payment listDecember 10, 2025 | za.investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDRIO, ELMD, INFU, and CVRX Company DescriptionsCVRx NASDAQ:CVRX$7.50 -0.30 (-3.85%) Closing price 04:00 PM EasternExtended Trading$7.51 +0.01 (+0.13%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.DarioHealth NASDAQ:DRIO$7.99 +0.54 (+7.25%) Closing price 04:00 PM EasternExtended Trading$8.01 +0.02 (+0.19%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Electromed NYSE:ELMD$25.81 +0.25 (+0.98%) Closing price 04:00 PM EasternExtended Trading$25.96 +0.15 (+0.56%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.InfuSystem NYSE:INFU$10.62 +0.23 (+2.21%) Closing price 04:00 PM EasternExtended Trading$10.61 -0.01 (-0.08%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
